| Patient | Charlotte Brontë |
|---|---|
| Date of birth | 1816-04-21 |
| Identifiers | MRN HR-NI025-SYN-TD; SSN (made up) 000-25-3804 |
| Document date | 1855-01-20 |
| Author | Eleanor Thwaite, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
One-week review of nausea and vomiting at 8 weeks; maternal-fetal medicine consultation today. [S]
Ms. Brontë returns one week after starting doxylamine-pyridoxine, two tablets at bedtime, at 8 weeks 1 day. The bedtime dose helps her sleep, but nausea lasts most of the day and she now vomits four or five times a day. She keeps down small amounts of water, tea, and dry crackers most days and passes urine normally. She feels lightheaded only when she gets up quickly. She has stopped writing and lies down most of the afternoon. She has had no pain, bleeding, fever, or diarrhea. Her PUQE-24 score is 11 (moderate), up from 10. She weighs 44.0 kg, 4.3 percent below her pre-pregnancy weight. She saw Dr. Oyelaran-Hughes of maternal-fetal medicine this morning. [S]
| Element | Detail |
|---|---|
| Interval change | Worse: vomiting four or five times a day |
| Intake | Small amounts of fluid and dry food kept down most days |
| Medication | Doxylamine-pyridoxine two tablets at bedtime; no daytime drowsiness |
| PUQE-24 | 11 (moderate), up from 10 |
| Weight | 44.0 kg, 4.3 percent below her pre-pregnancy weight |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; lightheaded only on standing quickly; no fever |
| Gastrointestinal | Positive | Nausea most of the day; vomiting four or five times a day; no pain or diarrhea |
| Genitourinary | Negative | Passing urine normally; no bleeding |
| Psychiatric | Positive | Discouraged but coping; no thoughts of self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe) | One tablet by mouth daily | Oral route | 1855-01-13 | active | S |
| Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, two tablets by mouth at bedtime | Two tablets by mouth at bedtime | Oral route | 1855-01-13 to 1855-01-20 | completed | S |
| Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, one tablet in the morning, one mid-afternoon, and two at bedtime (four a day) | One tablet in the morning, one mid-afternoon, and two at bedtime | Oral route | 1855-01-20 | active | S |
| Metoclopramide 10 mg oral tablet, one tablet by mouth three times a day before meals | One tablet by mouth three times a day, 30 minutes before meals | Oral route | 1855-01-20 to 1855-01-29 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1855-01-20 | Body height | 152 | cm | S |
| 1855-01-20 | Body weight | 44 | kg | S |
| 1855-01-20 | Body mass index (BMI) [Ratio] | 19 | kg/m2 | S |
| 1855-01-20 | Systolic blood pressure | 102 | mm[Hg] | S |
| 1855-01-20 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1855-01-20 | Heart rate | 92 | /min | S |
| 1855-01-20 | Respiratory rate | 14 | /min | S |
| 1855-01-20 | Body temperature | 36.8 | Cel | S |
| 1855-01-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1855-01-20 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 1855-01-20 | Potassium [Moles/volume] in Serum or Plasma | 3.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1855-01-20 | Chloride [Moles/volume] in Serum or Plasma | 99 | mmol/L | 98-107 mmol/L | Normal | S |
| 1855-01-20 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 26 | mmol/L | 22-29 mmol/L | Normal | S |
| 1855-01-20 | Urea nitrogen [Mass/volume] in Serum or Plasma | 11 | mg/dL | 6-20 mg/dL | Normal | S |
| 1855-01-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.58 | mg/dL | 0.4-0.9 mg/dL | Normal | S |
| 1855-01-20 | Glucose [Mass/volume] in Serum or Plasma | 74 | mg/dL | 70-99 mg/dL | Normal | S |
| 1855-01-20 | Ketones [Mass/volume] in Urine by Test strip | 40 | mg/dL | <=0 mg/dL | High | S |
Vital signs recorded on 1855-01-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Slight and tired; not distressed |
| Hydration | Mucous membranes slightly dry; no orthostatic drop in blood pressure; pulse 92 |
| Neck | Thyroid not enlarged |
| Abdomen | Soft and non-tender |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| First pregnancy at 38 (elderly primigravida), single live intrauterine pregnancy dated by ultrasound at 7 weeks 1 day | active | confirmed | O09.519 | S — Synthetic modern prenatal care anchored to the documented report that she was pregnant when she died; the pregnancy itself is questioned in one source (CLM-0019). |
| Nausea and vomiting of pregnancy, moderate (PUQE-24 score 10), with early weight loss, under evaluation for hyperemesis gravidarum | active | confirmed | O21.9 | S — Synthetic presenting concern at the index visit, superseded by the hyperemesis gravidarum diagnosis at the sick visit; her documented "perpetual nausea" is D and the hyperemesis reading of it is R. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PUQE-24 score (recorded in the note; no LOINC code found) | Every visit while nausea and vomiting last | Completed today | 11 (moderate), up from 10 |
| Examination | Weight against pre-pregnancy weight (46.0 kg), pulse, blood pressure, and hydration | Every visit while nausea and vomiting last | Completed today | 44.0 kg, down 4.3 percent; pulse 92; no orthostatic drop; mucous membranes slightly dry |
| Laboratory | Electrolytes, urea nitrogen, creatinine, and glucose | When vomiting is moderate or severe, daily while on intravenous fluids, and until stable on oral intake | Completed today | Normal; potassium 3.6 mmol/L at the low end |
| Laboratory | Urine ketones | With vomiting; recorded but not a measure of severity or dehydration | Completed today | 40 mg/dL |
| Laboratory | TSH and free T4 | In hyperemesis gravidarum; repeat at 16 to 18 weeks if suppressed | Not indicated | Not yet needed: no hyperemesis; to be checked if it develops |
| Medication safety | Antiemetic effects: drowsiness with doxylamine-pyridoxine; restlessness and abnormal movements with metoclopramide | Every visit and after each change | Completed today | No daytime drowsiness; metoclopramide starts today with counseling to stop it if restlessness or abnormal movements occur |
| Laboratory | First prenatal tests (blood group, antibody screen, rubella, hepatitis B, HIV, syphilis, hepatitis C, urine culture) | At the first prenatal visit | Completed today | Reviewed today: all normal or negative |
| Laboratory | Interferon-gamma release assay for tuberculosis | Once, for household tuberculosis exposure | Completed today | Negative; reviewed with her |
| Referral | Maternal-fetal medicine consultation | Early in a first pregnancy at 38 with worsening nausea and vomiting | Completed today | Seen today; escalation thresholds, screening, and aspirin plan agreed |
| Survey | Aneuploidy screening choice | Offered before 10 weeks | Completed today | Chose cell-free DNA from 10 weeks with a nuchal translucency scan; declined diagnostic testing unless a screen is positive |
| Examination | Blood pressure | Every prenatal visit | Completed today | 102/64 mmHg |
| Examination | Fetal heart | Every prenatal visit once audible by handheld Doppler (from about 10 to 12 weeks) | Not indicated | Not yet reliably audible by Doppler at 8 weeks; cardiac activity was seen on the dating scan a week ago |
Goal progress:
Guideline basis: ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018); The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024); Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020); Latent Tuberculosis Infection in Adults: Screening (2023)
Follow-up: Review in about three weeks, at 11 weeks, sooner by telephone or same day if the thresholds are reached. Next scheduled visit 1855-02-10: prenatal visit at 11 weeks: nausea and vomiting review and cell-free DNA screening. [S]